Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Simpler Method Devised to Produce Malaria Drug

A biochemistry group in the U.K. developed simpler and potentially more efficient techniques for producing a first-line drug for treating malaria. . . . → Read More: Simpler Method Devised to Produce Malaria Drug

Trial Shows Bioactive Glass Stops Bone Infections

Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics. . . . → Read More: Trial Shows Bioactive Glass Stops Bone Infections

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Genome Editing Builds Viral Disease Resistance in Pigs

Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds. . . . → Read More: Genome Editing Builds Viral Disease Resistance in Pigs

Online Pharmacies Seen Fueling Antibiotic Overuse

A study of pharmacies selling drugs online shows many of these sites offer antibiotics to consumers in the U.K. without prescriptions, which would be illegal in retail drug stores. . . . → Read More: Online Pharmacies Seen Fueling Antibiotic Overuse

Gates Grant Funding Malaria Control Test Products

Two universities in the U.K. are developing testing protocols for a new generation of technologies coming to market to prevent mosquitoes from spreading diseases. . . . → Read More: Gates Grant Funding Malaria Control Test Products

EU Project to Develop More Versatile Heart Pacemakers

An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions. . . . → Read More: EU Project to Develop More Versatile Heart Pacemakers

Novo Nordisk to Open Oxford Diabetes Research Center

The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K. . . . → Read More: Novo Nordisk to Open Oxford Diabetes Research Center

Allergy Immunotherapy Firm Raises $2M in Early Funds

A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round. . . . → Read More: Allergy Immunotherapy Firm Raises $2M in Early Funds

Neuro Device Company to Begin Clinical Trials in Europe

Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders. . . . → Read More: Neuro Device Company to Begin Clinical Trials in Europe